80 related articles for article (PubMed ID: 38658633)
21. Personalized health risk assessment based on single-cell RNA sequencing analysis of a male with 45, X/48, XYYY karyotype.
Koczkowska M; Jąkalski M; Birkholz-Walerzak D; Kostecka A; Iliszko M; Wójcik M; Lewandowski K; Milska-Musa K; Buckley PG; Drężek K; Juhas U; Kuziemska E; Maciejewska A; Pawłowski R; Wasąg B; Filipowicz N; Chojnowska K; Ławrynowicz U; Dumanski JP; Lipska-Ziętkiewicz BS; Mieczkowski J; Piotrowski A
Sci Rep; 2022 Dec; 12(1):20854. PubMed ID: 36460769
[TBL] [Abstract][Full Text] [Related]
22. Mosaic loss of Chromosome Y in aged human microglia.
Vermeulen MC; Pearse R; Young-Pearse T; Mostafavi S
Genome Res; 2022 Oct; 32(10):1795-1807. PubMed ID: 36041859
[TBL] [Abstract][Full Text] [Related]
23. Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.
Aristin Revilla S; Kranenburg O; Coffer PJ
Front Immunol; 2022; 13():903564. PubMed ID: 35874729
[TBL] [Abstract][Full Text] [Related]
24. Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality.
Sano S; Horitani K; Ogawa H; Halvardson J; Chavkin NW; Wang Y; Sano M; Mattisson J; Hata A; Danielsson M; Miura-Yura E; Zaghlool A; Evans MA; Fall T; De Hoyos HN; Sundström J; Yura Y; Kour A; Arai Y; Thel MC; Arai Y; Mychaleckyj JC; Hirschi KK; Forsberg LA; Walsh K
Science; 2022 Jul; 377(6603):292-297. PubMed ID: 35857592
[TBL] [Abstract][Full Text] [Related]
25. Clonal dynamics of haematopoiesis across the human lifespan.
Mitchell E; Spencer Chapman M; Williams N; Dawson KJ; Mende N; Calderbank EF; Jung H; Mitchell T; Coorens THH; Spencer DH; Machado H; Lee-Six H; Davies M; Hayler D; Fabre MA; Mahbubani K; Abascal F; Cagan A; Vassiliou GS; Baxter J; Martincorena I; Stratton MR; Kent DG; Chatterjee K; Parsy KS; Green AR; Nangalia J; Laurenti E; Campbell PJ
Nature; 2022 Jun; 606(7913):343-350. PubMed ID: 35650442
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive cancer-oriented biobanking resource of human samples for studies of post-zygotic genetic variation involved in cancer predisposition.
Filipowicz N; Drężek K; Horbacz M; Wojdak A; Szymanowski J; Rychlicka-Buniowska E; Juhas U; Duzowska K; Nowikiewicz T; Stańkowska W; Chojnowska K; Andreou M; Ławrynowicz U; Wójcik M; Davies H; Śrutek E; Bieńkowski M; Milian-Ciesielska K; Zdrenka M; Ambicka A; Przewoźnik M; Harazin-Lechowska A; Adamczyk A; Kowalski J; Bała D; Wiśniewski D; Tkaczyński K; Kamecki K; Drzewiecka M; Wroński P; Siekiera J; Ratnicka I; Jankau J; Wierzba K; Skokowski J; Połom K; Przydacz M; Bełch Ł; Chłosta P; Matuszewski M; Okoń K; Rostkowska O; Hellmann A; Sasim K; Remiszewski P; Sierżęga M; Hać S; Kobiela J; Kaska Ł; Jankowski M; Hodorowicz-Zaniewska D; Jaszczyński J; Zegarski W; Makarewicz W; Pęksa R; Szpor J; Ryś J; Szylberg Ł; Piotrowski A; Dumanski JP
PLoS One; 2022; 17(4):e0266111. PubMed ID: 35390022
[TBL] [Abstract][Full Text] [Related]
27. Colorectal liver metastasis: molecular mechanism and interventional therapy.
Zhou H; Liu Z; Wang Y; Wen X; Amador EH; Yuan L; Ran X; Xiong L; Ran Y; Chen W; Wen Y
Signal Transduct Target Ther; 2022 Mar; 7(1):70. PubMed ID: 35246503
[TBL] [Abstract][Full Text] [Related]
28. Cancer statistics, 2022.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
[TBL] [Abstract][Full Text] [Related]
29. Loss of Y and clonal hematopoiesis in blood-two sides of the same coin?
Ljungström V; Mattisson J; Halvardson J; Pandzic T; Davies H; Rychlicka-Buniowska E; Danielsson M; Lacaze P; Cavelier L; Dumanski JP; Baliakas P; Forsberg LA
Leukemia; 2022 Mar; 36(3):889-891. PubMed ID: 34725452
[No Abstract] [Full Text] [Related]
30. Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects.
Makaremi S; Asadzadeh Z; Hemmat N; Baghbanzadeh A; Sgambato A; Ghorbaninezhad F; Safarpour H; Argentiero A; Brunetti O; Bernardini R; Silvestris N; Baradaran B
Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572263
[TBL] [Abstract][Full Text] [Related]
31. A single-cell tumor immune atlas for precision oncology.
Nieto P; Elosua-Bayes M; Trincado JL; Marchese D; Massoni-Badosa R; Salvany M; Henriques A; Nieto J; Aguilar-Fernández S; Mereu E; Moutinho C; Ruiz S; Lorden P; Chin VT; Kaczorowski D; Chan CL; Gallagher R; Chou A; Planas-Rigol E; Rubio-Perez C; Gut I; Piulats JM; Seoane J; Powell JE; Batlle E; Heyn H
Genome Res; 2021 Oct; 31(10):1913-1926. PubMed ID: 34548323
[TBL] [Abstract][Full Text] [Related]
32. Leukocytes with chromosome Y loss have reduced abundance of the cell surface immunoprotein CD99.
Mattisson J; Danielsson M; Hammond M; Davies H; Gallant CJ; Nordlund J; Raine A; Edén M; Kilander L; Ingelsson M; Dumanski JP; Halvardson J; Forsberg LA
Sci Rep; 2021 Jul; 11(1):15160. PubMed ID: 34312421
[TBL] [Abstract][Full Text] [Related]
33. Integrated analysis of multimodal single-cell data.
Hao Y; Hao S; Andersen-Nissen E; Mauck WM; Zheng S; Butler A; Lee MJ; Wilk AJ; Darby C; Zager M; Hoffman P; Stoeckius M; Papalexi E; Mimitou EP; Jain J; Srivastava A; Stuart T; Fleming LM; Yeung B; Rogers AJ; McElrath JM; Blish CA; Gottardo R; Smibert P; Satija R
Cell; 2021 Jun; 184(13):3573-3587.e29. PubMed ID: 34062119
[TBL] [Abstract][Full Text] [Related]
34. Immune cells lacking Y chromosome show dysregulation of autosomal gene expression.
Dumanski JP; Halvardson J; Davies H; Rychlicka-Buniowska E; Mattisson J; Moghadam BT; Nagy N; Węglarczyk K; Bukowska-Strakova K; Danielsson M; Olszewski P; Piotrowski A; Oerton E; Ambicka A; Przewoźnik M; Bełch Ł; Grodzicki T; Chłosta PL; Imreh S; Giedraitis V; Kilander L; Nordlund J; Ameur A; Gyllensten U; Johansson Å; Józkowicz A; Siedlar M; Klich-Rączka A; Jaszczyński J; Enroth S; Baran J; Ingelsson M; Perry JRB; Ryś J; Forsberg LA
Cell Mol Life Sci; 2021 Apr; 78(8):4019-4033. PubMed ID: 33837451
[TBL] [Abstract][Full Text] [Related]
35. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
36. Sexual Dimorphism in Colon Cancer.
Abancens M; Bustos V; Harvey H; McBryan J; Harvey BJ
Front Oncol; 2020; 10():607909. PubMed ID: 33363037
[TBL] [Abstract][Full Text] [Related]
37. The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.
Kumagai S; Togashi Y; Kamada T; Sugiyama E; Nishinakamura H; Takeuchi Y; Vitaly K; Itahashi K; Maeda Y; Matsui S; Shibahara T; Yamashita Y; Irie T; Tsuge A; Fukuoka S; Kawazoe A; Udagawa H; Kirita K; Aokage K; Ishii G; Kuwata T; Nakama K; Kawazu M; Ueno T; Yamazaki N; Goto K; Tsuboi M; Mano H; Doi T; Shitara K; Nishikawa H
Nat Immunol; 2020 Nov; 21(11):1346-1358. PubMed ID: 32868929
[TBL] [Abstract][Full Text] [Related]
38. FoxP3
Saleh R; Elkord E
Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
[TBL] [Abstract][Full Text] [Related]
39. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects.
Li C; Jiang P; Wei S; Xu X; Wang J
Mol Cancer; 2020 Jul; 19(1):116. PubMed ID: 32680511
[TBL] [Abstract][Full Text] [Related]
40. Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer.
Zhang L; Li Z; Skrzypczynska KM; Fang Q; Zhang W; O'Brien SA; He Y; Wang L; Zhang Q; Kim A; Gao R; Orf J; Wang T; Sawant D; Kang J; Bhatt D; Lu D; Li CM; Rapaport AS; Perez K; Ye Y; Wang S; Hu X; Ren X; Ouyang W; Shen Z; Egen JG; Zhang Z; Yu X
Cell; 2020 Apr; 181(2):442-459.e29. PubMed ID: 32302573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
